|
06-2029
|
Statement of Work #01 between Novo Nordisk Research Center Seattle, Inc. (#Novo Nordisk#) and University of Florida Board of Trustees (#UF#)
Statement of Work #01 between Novo Nordisk Research Center Seattle, Inc. (#Novo Nordisk#) and University of Florida Board of Trustees (#UF#)
|
|
05-2028
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
02-2028
|
Prohormone convertase activity in human T1D pancreas tissue slices
Prohormone convertase activity in human T1D pancreas tissue slices
|
|
08-2027
|
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering
|
|
05-2027
|
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
|
|
01-2027
|
New way in delivering immunomodulatory drugs in T1D
New way in delivering immunomodulatory drugs in T1D
|
|
09-2026
|
Network for Pancreatic Organ Donors - nPOD
Network for Pancreatic Organ Donors - nPOD
|
|
08-2026
|
Evaluation of the safety, tolerability and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D
Evaluation of the safety, tolerability and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D
|
|
06-2026
|
Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D
Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D
|
|
06-2026
|
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
|
|
05-2026
|
Data Coordinating Center for Type 1 Diabetes TrialNet
Data Coordinating Center for Type 1 Diabetes TrialNet
|
|
02-2026
|
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
|
|
11-2025
|
Establishing immune, endocrine, and exocrine signatures of type 1 diabetes progression in longitudinally sampled peripheral blood from the ENDIA nested case control study
Establishing immune, endocrine, and exocrine signatures of type 1 diabetes progression in longitudinally sampled peripheral blood from the ENDIA nested case control study
|
|
07-2025
|
EVALUATION OF NOVEL COMPOUNDS POTENTIALLY TARGETING CENTRAL SIGMA RECEPTORS REGARDING THEIR ABILITY TO LOWER BLOOD GLUCOSE IN DIABETIC MICE.
EVALUATION OF NOVEL COMPOUNDS POTENTIALLY TARGETING CENTRAL SIGMA RECEPTORS REGARDING THEIR ABILITY TO LOWER BLOOD GLUCOSE IN DIABETIC MICE.
|
|
07-2025
|
Human Atlas of Neonatal Developmental and Early Life Pancreas / Immunity (HANDEL)-P/I Continuation
Human Atlas of Neonatal Developmental and Early Life Pancreas / Immunity (HANDEL)-P/I Continuation
|
|
06-2025
|
Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D
Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D
|
|
06-2025
|
TrialNet Clinical Center infrastructure support services
TrialNet Clinical Center infrastructure support services
|
|
06-2025
|
TrialNet Clinical Center infrastructure support services
TrialNet Clinical Center infrastructure support services
|
|
06-2025
|
Data Coordinating Center for Type 1 Diabetes TrialNet
Data Coordinating Center for Type 1 Diabetes TrialNet
|
|
06-2025
|
Data Coordinating Center for Type 1 Diabetes TrialNet
Data Coordinating Center for Type 1 Diabetes TrialNet
|
|
04-2025
|
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
|
|
12-2024
|
Deciphering fatty acid metabolism in type 1 diabetes using imaging mass spectrometry
Deciphering fatty acid metabolism in type 1 diabetes using imaging mass spectrometry
|
|
12-2024
|
Human Pancreas Analysis Program-T2D
Human Pancreas Analysis Program-T2D
|
|
12-2024
|
Human Pancreas Analysis Program-T2D
Human Pancreas Analysis Program-T2D
|
|
08-2024
|
Experimental and natural SARS-CoV-2 infection of the human pancreas
Experimental and natural SARS-CoV-2 infection of the human pancreas
|
|
08-2024
|
Investigating type 1 diabetes pathogenesis using the live pancreas tissue slice platform.
Investigating type 1 diabetes pathogenesis using the live pancreas tissue slice platform.
|
|
09-2023
|
The Network for Pancreatic Organ donors with Diabetes (nPOD) : A Collaborative Type 1 Diabetes Research Project
The Network for Pancreatic Organ donors with Diabetes (nPOD) : A Collaborative Type 1 Diabetes Research Project
|
|
09-2023
|
Network for Pancreatic Organ Donors - nPOD
Network for Pancreatic Organ Donors - nPOD
|
|
09-2023
|
Collaborative Type 1 Diabetes Research Project: The Network for Pancreatic Organ donors with Diabetes (nPOD)
Collaborative Type 1 Diabetes Research Project: The Network for Pancreatic Organ donors with Diabetes (nPOD)
|
|
06-2023
|
A 3D Tissue Map of the Human Lymphatic System
A 3D Tissue Map of the Human Lymphatic System
|
|
05-2023
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
09-2022
|
T cell receptor sequencing in type 1 diabetes - biomarker discovery and technology development
T cell receptor sequencing in type 1 diabetes - biomarker discovery and technology development
|
|
08-2022
|
Validating KIRAs as B cell-sparing drugs in islets from human patients with T1D
Validating KIRAs as B cell-sparing drugs in islets from human patients with T1D
|
|
08-2022
|
Validating KIRAs as B cell-sparing drugs in islets from human patients with T1D
Validating KIRAs as B cell-sparing drugs in islets from human patients with T1D
|
|
08-2022
|
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering
Interdisciplinary Graduate Program in Type 1 Diabetes and Biomedical Engineering
|
|
06-2022
|
Blanche J. Salisbury Diabetes Research Fund
Blanche J. Salisbury Diabetes Research Fund
|
|
06-2022
|
Data coordinating Center for Type 1 Diabetes TrialNet (UC4)###
Data coordinating Center for Type 1 Diabetes TrialNet (UC4)###
|
|
06-2022
|
Data coordinating Center for Type 1 Diabetes TrialNet (UC4)###
Data coordinating Center for Type 1 Diabetes TrialNet (UC4)###
|
|
03-2022
|
B-lymphocyte targeting therapies for autoimmune diabetes
B-lymphocyte targeting therapies for autoimmune diabetes
|
|
03-2022
|
B-lymphocyte targeting therapies for autoimmune diabetes
B-lymphocyte targeting therapies for autoimmune diabetes
|
|
08-2021
|
Identification of Anti-Neo-Antigen AutoAntibodies in Type 1 Diabetes
Identification of Anti-Neo-Antigen AutoAntibodies in Type 1 Diabetes
|
|
08-2021
|
Identification of Anti-Neo-Antigen AutoAntibodies in Type 1 Diabetes
Identification of Anti-Neo-Antigen AutoAntibodies in Type 1 Diabetes
|
|
07-2021
|
Targeted nanodelivery in T1D
Targeted nanodelivery in T1D
|
|
07-2021
|
Integrated Program for Human Pancreas Procurement and Analysis
Integrated Program for Human Pancreas Procurement and Analysis
|
|
07-2021
|
Integrated Program for Human Pancreas Procurement and Analysis
Integrated Program for Human Pancreas Procurement and Analysis
|
|
04-2021
|
The George S. Eisenbarth nPOD Award for Team Science
The George S. Eisenbarth nPOD Award for Team Science
|
|
10-2020
|
2020 nPOD Annual Meeting Conference Grant
2020 nPOD Annual Meeting Conference Grant
|
|
08-2020
|
In situ characterization of human alpha cell physiology in type 1 diabetes pathogenesis
In situ characterization of human alpha cell physiology in type 1 diabetes pathogenesis
|
|
08-2020
|
In situ characterization of human alpha cell physiology in type 1 diabetes pathogenesis
In situ characterization of human alpha cell physiology in type 1 diabetes pathogenesis
|
|
08-2020
|
Neural regulation of alpha cell function and dysregulation in type 1 diabetes
Neural regulation of alpha cell function and dysregulation in type 1 diabetes
|
|
05-2020
|
Single-Cell Analyses of Human Islets in T1D Using Highly Multiplexed Imaging
Single-Cell Analyses of Human Islets in T1D Using Highly Multiplexed Imaging
|
|
05-2020
|
Roles of the Insulin-like Growth Factor Axis in Pre-Type 1 Diabetes Immune Regulation
Roles of the Insulin-like Growth Factor Axis in Pre-Type 1 Diabetes Immune Regulation
|
|
05-2020
|
A Novel Combination Therapy for Type 1 Diabetes Prevention
A Novel Combination Therapy for Type 1 Diabetes Prevention
|
|
04-2020
|
TrialNet: University of Florida Clinical Center and Network
TrialNet: University of Florida Clinical Center and Network
|
|
01-2020
|
Human Atlas of the Neonatal Development and Early Life Pancreas (Handel-P)
Human Atlas of the Neonatal Development and Early Life Pancreas (Handel-P)
|
|
10-2019
|
2019 nPOD Annual Meeting Conference Grant
2019 nPOD Annual Meeting Conference Grant
|
|
10-2019
|
The JDRF nPOD Viral Work group: nPOD-V
The JDRF nPOD Viral Work group: nPOD-V
|
|
10-2019
|
The JDRF nPOD Viral Work group: nPOD-V
The JDRF nPOD Viral Work group: nPOD-V
|
|
06-2019
|
Serum protein biomarkers for predicting type 1 diabetes development
Serum protein biomarkers for predicting type 1 diabetes development
|
|
06-2019
|
Serum protein biomarkers for predicting type 1 diabetes development
Serum protein biomarkers for predicting type 1 diabetes development
|
|
06-2019
|
Biomaterial Delivery System for Type 1 Diabetes Vaccine
Biomaterial Delivery System for Type 1 Diabetes Vaccine
|
|
06-2019
|
Biomaterial Delivery System for Type 1 Diabetes Vaccine
Biomaterial Delivery System for Type 1 Diabetes Vaccine
|
|
06-2019
|
Characterization of T cell Autoreactivity in Type 1 Diabetes
Characterization of T cell Autoreactivity in Type 1 Diabetes
|
|
12-2018
|
nPOD Annual Meeting Costs - 2018
nPOD Annual Meeting Costs - 2018
|
|
06-2018
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
03-2018
|
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
|
|
03-2018
|
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
|
|
03-2018
|
NPOD Coordinating Center
NPOD Coordinating Center
|
|
02-2018
|
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
|
|
02-2018
|
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
|
|
12-2017
|
nPOD Annual Meeting Costs - 2017 & 2018
nPOD Annual Meeting Costs - 2017 & 2018
|
|
12-2017
|
Helmsley Trust Diabetes Cell Repository
Helmsley Trust Diabetes Cell Repository
|
|
12-2017
|
Helmsley Trust Diabetes Cell Repository
Helmsley Trust Diabetes Cell Repository
|
|
06-2017
|
Assessment of cytokines in human islets from patients with type 1 diabetes
Assessment of cytokines in human islets from patients with type 1 diabetes
|
|
06-2017
|
Assessment of cytokines in human islets from patients with type 1 diabetes
Assessment of cytokines in human islets from patients with type 1 diabetes
|
|
02-2017
|
NIDDK Type 1 diabetes trialnet data coordinating center
NIDDK Type 1 diabetes trialnet data coordinating center
|
|
02-2017
|
NIDDK Type 1 diabetes trialnet data coordinating center
NIDDK Type 1 diabetes trialnet data coordinating center
|
|
12-2016
|
Measuring markers and cytokines in human serum and plasma to determine phenotype and a genotype correlations in Type 1 Diabetes
Measuring markers and cytokines in human serum and plasma to determine phenotype and a genotype correlations in Type 1 Diabetes
|
|
08-2016
|
The JDRF nPOD Viral Work Group: nPOD V
The JDRF nPOD Viral Work Group: nPOD V
|
|
06-2016
|
Identifying the contribution of beta cell dysfunction and autoimmunity to the pathogenesis of type 1 diabetes
Identifying the contribution of beta cell dysfunction and autoimmunity to the pathogenesis of type 1 diabetes
|
|
01-2016
|
Immune Tolerance Network
Immune Tolerance Network
|
|
12-2015
|
Helmsley Trust Diabetes Cell Repository
Helmsley Trust Diabetes Cell Repository
|
|
12-2015
|
Helmsley Trust Diabetes Cell Repository
Helmsley Trust Diabetes Cell Repository
|
|
12-2015
|
Brehm Coalition-Dedifferentiation
Brehm Coalition-Dedifferentiation
|
|
08-2015
|
Protein markers to type 1 diabetes progression
Protein markers to type 1 diabetes progression
|
|
06-2015
|
Sanford Fellowship Project
Sanford Fellowship Project
|
|
04-2015
|
The Network for Open Source Data in Type 1 Diabetes
The Network for Open Source Data in Type 1 Diabetes
|
|
02-2015
|
Reversing Type 1 Diabetes After it is Established: A Pil
Reversing Type 1 Diabetes After it is Established: A Pil
|
|
12-2014
|
JDRF/ITN Partnership in Immune Tolerance: A Consortium
JDRF/ITN Partnership in Immune Tolerance: A Consortium
|
|
12-2014
|
Characterizing The Autoimmune Microbiome For Type 1 Diab
Characterizing The Autoimmune Microbiome For Type 1 Diab
|
|
12-2014
|
nPOD Coordinating Center
nPOD Coordinating Center
|
|
08-2014
|
Protein markers to type 1 diabetes progression
Protein markers to type 1 diabetes progression
|
|
04-2014
|
Preventing Type 1 Diabetes by oral delivery of plant-der
Preventing Type 1 Diabetes by oral delivery of plant-der
|
|
03-2014
|
2014 JDRF-Helmsley nPOD Annual Scientific Symposium
2014 JDRF-Helmsley nPOD Annual Scientific Symposium
|
|
02-2014
|
Ex Vivo Analysis of the Cell Educator System
Ex Vivo Analysis of the Cell Educator System
|
|
02-2014
|
The role of beta cell (dys)function ... (Rowe, P.)
The role of beta cell (dys)function ... (Rowe, P.)
|
|
01-2014
|
nPOD-V Meeting in Victoria
nPOD-V Meeting in Victoria
|
|
12-2013
|
The Diabetes Center Summit: Operations, Management and Q
The Diabetes Center Summit: Operations, Management and Q
|
|
12-2013
|
JDRF/ITN Partnership in Immune Tolerance: A Consortium
JDRF/ITN Partnership in Immune Tolerance: A Consortium
|
|
09-2013
|
Cord Blood Therapies for TYpe 1 DIabetes
Cord Blood Therapies for TYpe 1 DIabetes
|
|
08-2013
|
nPOD Expansion
nPOD Expansion
|
|
04-2013
|
Eval. optimal dose and therapeutic durability of CTB-
Eval. optimal dose and therapeutic durability of CTB-
|
|
04-2013
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
12-2012
|
JDRF/ITN Partnership in Immune Tolerance: A Consortium
JDRF/ITN Partnership in Immune Tolerance: A Consortium
|
|
12-2012
|
IL-2 Deficiency Associated Neuropathology
IL-2 Deficiency Associated Neuropathology
|
|
12-2012
|
Organ Processing and Pathology Core
Organ Processing and Pathology Core
|
|
09-2012
|
Anti-CD20 and oral insulin on reversal of T1D in NOD mic
Anti-CD20 and oral insulin on reversal of T1D in NOD mic
|
|
08-2012
|
A STUDY OF MODEL B-CELLS IN DIABETES TREATMENT
A STUDY OF MODEL B-CELLS IN DIABETES TREATMENT
|
|
07-2012
|
Smart Home-based Health Platform for Behavioral Monitori
Smart Home-based Health Platform for Behavioral Monitori
|
|
05-2012
|
Anti-CD20 and oral insulin on reversal of type 1 diabete
Anti-CD20 and oral insulin on reversal of type 1 diabete
|
|
05-2011
|
Structure Guided Small Molecule Targeting of Anti-Insuli
Structure Guided Small Molecule Targeting of Anti-Insuli
|
|
03-2011
|
Short Course G-CSF as Immunomodulatory Therapy for Type
Short Course G-CSF as Immunomodulatory Therapy for Type
|
|
02-2011
|
STAT5 Dysfunction as a Biomarker for Autoimmune Disease
STAT5 Dysfunction as a Biomarker for Autoimmune Disease
|
|
08-2010
|
ARRA Supplement P01AI042288
ARRA Supplement P01AI042288
|
|
08-2010
|
Ident of Autoantigens in T1D by Protein Microarray
Ident of Autoantigens in T1D by Protein Microarray
|
|
07-2010
|
Dendretic Cells and the Prevention of Type 1 Diabetes
Dendretic Cells and the Prevention of Type 1 Diabetes
|
|
06-2010
|
MISCELLANEOUS SPONSORS
MISCELLANEOUS SPONSORS
|
|
08-2009
|
Elan Pharmaceuticals PBMC Processing
Elan Pharmaceuticals PBMC Processing
|
|
07-2009
|
Cord Blood Immunoregulation of Type 1 Diabetes
Cord Blood Immunoregulation of Type 1 Diabetes
|
|
06-2009
|
Novel Mechanisms and Therapies Targeting Dysfunctional
Novel Mechanisms and Therapies Targeting Dysfunctional
|
|
06-2009
|
Regulatory T Cell Deffects in Human T1D
Regulatory T Cell Deffects in Human T1D
|
|
06-2009
|
Ident of Autoantigens in T1D by Protein Microarray
Ident of Autoantigens in T1D by Protein Microarray
|
|
05-2009
|
PPG - Immunoregulatory Based Therapies for TYpe 1 Diabet
PPG - Immunoregulatory Based Therapies for TYpe 1 Diabet
|
|
05-2008
|
Immunoregulatory Based Therapies for Type 1 Diabetes
Immunoregulatory Based Therapies for Type 1 Diabetes
|
|
06-2007
|
Defining the Role of CFTR in Cystic Fibrosis Related Dia
Defining the Role of CFTR in Cystic Fibrosis Related Dia
|
|
06-2007
|
Novel Mechanisms and Therapies Targeting Dysfunctional E
Novel Mechanisms and Therapies Targeting Dysfunctional E
|
|
05-2007
|
Immunoregulatory Based Therapies for Type 1 Diabetes
Immunoregulatory Based Therapies for Type 1 Diabetes
|
|
05-2007
|
CORE A: IMMUNE FUNCTION AND THE PROGRESSION TO TYPE I
CORE A: IMMUNE FUNCTION AND THE PROGRESSION TO TYPE I
|
|
01-2007
|
Enhancement of Islet Viability
Enhancement of Islet Viability
|
|
06-2006
|
The Origins of Cystic Fibrosis Related Diabetes
The Origins of Cystic Fibrosis Related Diabetes
|
|
06-2006
|
JDRF Gene Therapy Center
JDRF Gene Therapy Center
|
|
05-2006
|
MECHANISMS OF IMMUNOTHERAPY IN IDD PREVENTION TRIALS
MECHANISMS OF IMMUNOTHERAPY IN IDD PREVENTION TRIALS
|
|
05-2006
|
Immuno Based Therapies for the Prev and Reversal of T1
Immuno Based Therapies for the Prev and Reversal of T1
|
|
07-2005
|
CORE C:TRANSDUCTION OF HEPATOCYTES WITH RECOMBINANT AAV
CORE C:TRANSDUCTION OF HEPATOCYTES WITH RECOMBINANT AAV
|
|
12-2004
|
GENE THERAPY CENTER FOR THE PREVENTION OF DIABETES AND D
GENE THERAPY CENTER FOR THE PREVENTION OF DIABETES AND D
|
|
11-2004
|
MUTATION DETECTION IN MURINE STAT GENE FAMILY
MUTATION DETECTION IN MURINE STAT GENE FAMILY
|
|
10-2004
|
A Novel Gene Therapy for improving Islet Transplantation
A Novel Gene Therapy for improving Islet Transplantation
|
|
07-2004
|
DENDRITIC CELL AND THE PREVENTION OF TYPE 1 DIABETES
DENDRITIC CELL AND THE PREVENTION OF TYPE 1 DIABETES
|
|
06-2004
|
CYTOKINE GENE THERAPY FOR THE PREVENTION OF TYPE 1 DIABE
CYTOKINE GENE THERAPY FOR THE PREVENTION OF TYPE 1 DIABE
|
|
06-2003
|
THE ROLE OF HEME OXYGENASE-1 IN PANCREATIC B-CELL SURVIV
THE ROLE OF HEME OXYGENASE-1 IN PANCREATIC B-CELL SURVIV
|
|
05-2003
|
DQB*0602 RELATIVES--MECHANISMS FOR DIABETES PROTECTION
DQB*0602 RELATIVES--MECHANISMS FOR DIABETES PROTECTION
|
|
01-2003
|
JDF 4-2000-947
JDF 4-2000-947
|
|
04-2002
|
ADMINISTRATIVE SUPPLEMENTAL SUPPORT: MECHANISMS OF
ADMINISTRATIVE SUPPLEMENTAL SUPPORT: MECHANISMS OF
|
|
01-2002
|
CYTOKINE MEDIATED GENE THERAPY FOR THE PREVENTION AND
CYTOKINE MEDIATED GENE THERAPY FOR THE PREVENTION AND
|
|
09-2001
|
MECHANISMS OF IMMUNOTHERAPY INIDD PREVENTION TRIALS
MECHANISMS OF IMMUNOTHERAPY INIDD PREVENTION TRIALS
|
|
08-2001
|
ADMINISTRATIVE SUPPLEMENT: IMMUNE FUNCTION and LOW RISK
ADMINISTRATIVE SUPPLEMENT: IMMUNE FUNCTION and LOW RISK
|
|
08-2001
|
CORE A: IMMUNE FUNCTION IN LOW RISK GENOTYPES IN IDD
CORE A: IMMUNE FUNCTION IN LOW RISK GENOTYPES IN IDD
|
|
08-2001
|
PROJECT III: IMMUNE FUNCTION IN LOW RISK GENOTYPES IN ID
PROJECT III: IMMUNE FUNCTION IN LOW RISK GENOTYPES IN ID
|
|
05-2000
|
DQB1*0602 RELATIVES: MECHANISMS CONFERRING DIABETES
DQB1*0602 RELATIVES: MECHANISMS CONFERRING DIABETES
|
|
03-2000
|
PHASE I/II TRIAL OF HOKT3 GAMMA 1 (A1A-A1A) FOR TREATMEN
PHASE I/II TRIAL OF HOKT3 GAMMA 1 (A1A-A1A) FOR TREATMEN
|
|
03-2000
|
THE ROLE FOR B-LYMPHOCYTES IN THE DEVELOPMENT OF ANTI-GA
THE ROLE FOR B-LYMPHOCYTES IN THE DEVELOPMENT OF ANTI-GA
|
|
01-1999
|
AUTOIMMUNITY TO GLUTAMATE DE- CARBOXYLASE IN IDD
AUTOIMMUNITY TO GLUTAMATE DE- CARBOXYLASE IN IDD
|
|
12-1998
|
INSULIN SECRETION and LYMPHOCYTE RECEPTOR EXPRESSION: KEY
INSULIN SECRETION and LYMPHOCYTE RECEPTOR EXPRESSION: KEY
|
|
09-1998
|
CELLUAR IMMUNITY TO GLOUTAMATE DECARBOXYLASE IN IDD
CELLUAR IMMUNITY TO GLOUTAMATE DECARBOXYLASE IN IDD
|